SPECIAL REPORT
MOST SHARED
- Home Prices Start to Stabilize In the US as Sales Pick Up
- Dow Industrials at New Highs—But Other Indices Lag
- S&P Stocks Trading at New 52-Week Highs
- Future of Marketing
- Israel: Leader of Business Innovation
- Rock Band Weezer Uses Snuggie to Promote New Album
- Dow Up Over 100 After G20 Stimulus Pledge
- Why Health Care Bill Is Facing Such a Tough Fight in Senate
- Priceline Crushes Profit Forecasts; Shares Jump
- Warren Buffett to Sell Stakes In Union Pacific & Norfolk Southern
- Nov. 9: Unusual Volume Leaders
- The Battered Businesses Behind Housing
- Modern Warfare 2's Record-Breaking Launch
- Merck’s Mega-Monday Morning
- Why are Traders Bullish on This Food Company?
- Profiting From Natural Gas: Strategists
- S&P Stocks Trading at New 52-Week Highs
- Shopping for Answers
- Buffett to Sell Stakes in Norfolk Southern, Union Pacific
- Do You Know Your Coca-Cola Myths?
- Electronic Arts Beats Street, Announces 1,500 Job Cuts
- Time Is Here to Look at Overseas Stocks: Bill Gross
- Home Prices Start to Stabilize In the US as Sales Pick Up
- Flaw in US Data Overstates Growth, Productivity
- Priceline Crushes Profit Forecasts; Shares Jump
- 'Modern Warfare 2' May Be Biggest Event This Year
- Sprint to Cut Up to 2,500 Jobs, Sees Charge
RSS FEED
Pharma's Market
![]() |
Up until last month, AMGN [AMGN
Loading...
()
] had been atop the list of pharmaceutical manufacturer donors and PFE [PFE
Loading...
()
] was in a close second. But the CRP says they flip-flopped in the most recent month that figures are available. So far, in the 2008 election cycle, Pfizer's given $862,000 to candidates and Amgen has forked over $852,000.
And the two companies have different preferences. PFE has donated 52 percent of its cash to Democrats, 48 percent to Republicans. While AMGN has put 49 percent on Dems and 51 percent on the GOP. GlaxoSmithKline [GSK
Loading...
()
] is a distant third with $661,000 in political contributions, thus far.
Based on Federal Election Commission data released on April 28th the drugmakers, overall, have split their money evenly between the two parties. That is in stark contrast to recent election cycles.
In 2006, pharma gave 28 percent to Democrats, 70 percent to Republicans. In the last presidential election year it was 30/70 respectively. And the one before that 23/77. Even with all of their industry investigations and anti-pharmaceutical lobbying/influence rhetoric, Democrats are grabbing more cash from the companies.
Sen. Barack Obama is still number one. He has taken in $636,000 from the "pharmaceuticals/health products" sector.
Sen. Hillary Clinton is in second place with $568,000. And Sen. John McCain has moved up into fifth place (among current and former presidential candidates) at $173,000.
The financial ledger of the campaigns isn't the only place where drugs and politics are mixing it up. In his weekly piece in the Sunday New York Times, Op-Ed page columnist Frank Rich called out Congressional Republicans for coming up with what he called the "Obamaesque" tagline, "The Change You Deserve." What's the problem with that? It was a tagline for Wyeth's [WYE
Loading...
()
] antidepressant Effexor. Oops.
By the way, the CRP website which puts a ton of information at your fingertips, has also received a nice facelift.
Questions? Comments?










